A new and general procedure for refolding mutant Bowman-Birk-type proteinase inhibitors on trypsin-Sepharose as a matrix with complementary structure  by Flecker, Peter
Volume 252, number 1,2, 153-157 July 1989 FEB 07430 
A new and general procedure for refolding mutant Bowman-Birk- 
type protecnase inhibitors on trypsin-Sepharose as a matrix with 
complementary structure 
Peter Flecker 
Enzymology Department, Paul Ehrlich Znstitut, Paul Ehrlich Str. 42-44,6000 Frankfurt/M 70, FRG 
Received 23 May 1689; revised version received 9 June 1989 
The trypsin-reactive subdomain of the Bowman-Birk-inhibitor of serine proteinases i shown to be highly vulnerable to 
perturbations induced by single amino acid replacements. Dramatic deviations from a stoichiometric 1:l ratio to the 
chymotrypsin-reactive subdomain used as an internal standard occur with all variants after renaturation in solution. A 
stoichiometric 1: 1 ratio of subdomains is achieved via a new refolding procedure on trypsin-Sepharose asa matrix with 
complementary structure. 
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1. INTRODUCTION troscopic properties [7]; however, the chymotryp- 
sin-reactive part is more sensitive in this respect. 
The kinetic analysis of protein variants modified We have recently described an approach through 
via genetic techniques has become a widely ac- the use of recombinant DNA techniques to a 
cepted tool for analyzing relationships between Bowman-Birk-type proteinase inhibitor via 
structure and activity in proteins [ 11. However, chemically synthesizing the gene [8] and decided to 
even very slight changes in the amino acid sequence start with site-directed mutagenesis in the trypsin- 
of a protein might affect other structural elements reactive head while using the chymotrypsin- 
important for its functional properties. Deleterious reactive subdomain as an internal standard for the 
effects on the stability [2] and refolding properties detection of structural perturbations. The serious 
[3] of a protein should always be considered. problems due to refolding that were encountered 
Unambiguous distinction of structural from func- during the work on the variants, however, pro- 
tional mutants is therefore required for a clear-cut mpted us to devise a modified protocol to deal with 
interpretation of results. such difficulties. 
The Bowman-Birk inhibitor (fig. 1) of serine pro- 
teinases [4,5] was considered to be a very suitable 
protein for this purpose because it contains two 
closely aligned subdomains with distinct trypsin- 
and chymotrypsin-inhibitory activities. Both sub- 
domains are not completely independent of each 
other as regards their activities [6] and spec- 
2. MATERIALS AND METHODS 
All materials and general methods, details of expression, 
CNBr cleavage, refolding procedure for parent Bowman-Birk- 
type proteinase inhibitor and technique for assaying residual 
trypsin activities have been described [8]. The final concentra- 
tion of trypsin in assays was 5.83 x IO-’ M. Chymotrypsin- 
inhibitor complexes were formed in 100 ~1 buffer [SO mM Tris- 
Cl (PH 7.5), 20 mM CaCls] for 15 min and residual enzyme ac- 
tivities were assayed by the method of Erlanger et al. [9) using 
N-glutaryl-L-phenylalanine p-nitroanilide (GPNA) as synthetic 
substrate. Bovine chymotrypsin, containing a minimum of 95% 
of active material, and the synthetic substrate were obtained 
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Fig.1. Covalent structure of the parent Bowman-Birk-type proteinase inhibitor. Single amino acid replacements in the trypsin-reactive 
subdomain are shown. 
from Sigma. The flnalchymotrypsin concentration in the assays 
was 4.16 x 10-s M. Stock solutions of inhibitor were ap- 
propriately diluted for assays of residual proteinase activities. 
The amounts of inhibitor (in ,cg) were calculated from the ex- 
pressions 
Z = [E’] VMJR 
and 
R = l-q/vI0’ 
where [E”] represents the final concentration of proteinase (in 
mol/l), V the final volume of the enzyme assays (6 x 10e4 I), 
Mr denoting the value for the inhibitor Mr (8 x 10’ pg/mol), p 
the volume of the aliquot of diluted stock solution at the 
equivalence point and Vat the volume of diluted stock solution 
corresponding to the total amount of inhibitor. The equivalence 
points for titrations with chymotrypsin were evaluated by using 
the graphic method of Dixon [lo] as shown in fig2b,d, since the 
ratio [E”]/Kr [ll] under the present assay conditions is within 
the range for flat inhibition curves [12]. The parent protein [8] 
was verified as giving a stoichiometric 1: 1 ratio of both 
proteinase-reactive subdomains. 
The variants were expressed in E. coli W 3110 as fusion pro- 
teins to a &galactosidase fragment and cleaved with CNBr as 
described in [8]. An IMA disintegrator (IMA, Zeppelinheim, 
FRG) operating at 5000 rpm was used for disintegration of cells 
instead of a French press. 
Refolding and affinity chromatography for mutant pro- 
teinase inhibitors were performed as follows: 32 mg crude 
CNBr cleavage mixture ‘were incubated in 240~1 reduc- 
tion/denaturation buffer, containing 2 M Tris-Cl (pH 8), 0.2010 
EDTA, 6 M guanidinium chloride and 2 M 2-mercaptoethanol 
at 37°C for 18 h, and then added dropwise to 240 ml renatura- 
tion buffer, comprising 80 mM Tris-Cl (pH 8), 0.1 mM EDTA 
and 0.2 mM oxidized glutathione at 37°C with vigorous stirr- 
ing. The refolding mixture was shaken for 60 min at 37”C, 
trypsin-Sepharose [8] added and shaking continued at 32°C for 
90 min. The matrix was transferred to a column and washed 
with 50 ml of 0.1 M sodium borate (pH 7.6) containing 10 mM 
CaC12, 50 ml of 10 mM CaClr and 10 mM HCl in the case of 
P; -Pro and 5 mM HCl for P; -Pro and Pj -Leu variants, respec- 
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tively, at 4°C. The Pi-Pro variant was eluted with 100 mM 
HCI, the others being eluted with 50 mM HCl at a flow rate of 
approx. 0.2 ml/min. 5-ml fractions were collected, SO-PI ali- 
quots being assayed for residual trypsin activities (cf. fig.3). 
The active fractions were pooled, diluted with water and 
lyophilized. The-samples gave single bands at 8 kDa on SDS 
gels and single active peaks on reversed-phase HPLC with 
retention times which are in accordance with that of the parent 
protein [8]. 
3. RESULTS 
Gene sequences coding for the following three 
variants: Pi-Ser - Pro, Pi-Asn - Pro and 
Pj -Pro - Leu in the trypsin-reactive subdomain 
of the Bowman-Birk-type proteinase inhibitor 
(fig. 1) were constructed by site-directed modifica- 
tion of the published [8] synthetic gene in order to 
address several questions on the mechanism [ 131 of 
proteinase inhibitors. These single amino acid 
replacements do not occur in any of the natural in- 
hibitors of the Bowman-Birk family [5]. Details of 
their construction, biochemical characterization 
and kinetic properties will be published somewhere 
else. 
The gene sequences encoding these variants were 
cloned into the EcoRI and MI restriction sites of 
plasmid pLZP WBl and expressed as fusion pro- 
teins with a fi-galactosidase fragment in E. coli 
W 3110 as described for the parent inhibitor [8]. 
Up to 400 mg of crude fusion-proteins were ob- 
tained from 1 1 of bacterial culture. The resulting 
fusion proteins were treated with cyanogen 
bromide in 70% formic acid and used for refolding 
experiments without further purification [8]. 
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Experiments on renaturation in solution under 
the conditions described for the parent protein [8] 
were unsuccessful with the variants, however: the 
relative amount of trypsin-reactive material was 
reduced dramatically reaching zero in the case of 
the Pi-Pro-variant, or a small fraction of the 
chymotrypsin-reactive subdomain in the other two 
variants (cf. a,c in figs 4-6). 
The majority of the material comprising the 
trypsin-reactive subdomain is apparently 
distributed in the form of non-active conformers. 
This indicates the occurrence of local structural 
perturbations in the trypsin-reactive region of 
these variants. 
All attempts at improving this unfavourable 
ratio through systematic variation of the refolding 
conditions were without success. Experiments on 
refolding in the presence of thioredoxin from Cor- 
ynebacterium nephridii according to Pigiet and 
Schuster [14] also failed to yield the correct levels 
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R= (Veq/Vtot).lO-3 R= (Veq/Vtot)*10-2 
for the trypsin-reactive subdomain. Nevertheless, 
refolding in the presence of trypsin-Sepharose 
combined with subsequent affinity chromatogra- 
phy, as described in section 2 and fig.3, was found 
to improve this disappointing situation dramatical- 
ly. This is demonstrated on comparison of the 
titration curves of the Pi-Pro variant refolded in 
the presence (fig.2a) and absence (fig.2c) of 
trypsin-Sepharose. In contrast, the chymotrypsin- 
titration curves in fig.2b,d are virtually superim- 
posable. This shows that the amount of the inter- 
nal standard is not affected by the presence of 
trypsin-Sepharose within experimental error. 
The results of all titration experiments on both 
proteinase-reactive subdomains obtained via 
refolding in the respective absence and presence of 
trypsin-Sepharose are summarized in figs 4-6. The 
amounts of trypsin- and chymotrypsin-reactive 
material correspond to the heights of filled and 
hatched bars, respectively. The relative amounts of 
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0.1 
Fig.2. Titration of both subdomains of the Pi-Pro variant of the Bowman-Birk-type inhibitor. Refolding in the presence of trypsin- 
Sepharose (0): titration with trypsin (curve 2a) and chymotrypsin (curve 2b). Refolding in the absence of trypsin-Sepharose (0): 
titration with trypsin (curve 2c) and chymotrypsin (curve 2d). 
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Fig.3. Affinity chromatography of the Pi-Pro variant after 
refolding in the presence of trypsin-Sepharose. One inhibitory 
unit (IU) is defined as the amount of inhibitor (in pg) required 
to inhibit trypsin at a concentration of 1 fig/ml. 
trypsin-reactive and chymotrypsin-reactive subdo- 
mains are shifted toward the correct values, within 
experimental error, for the stoichiometric ratio 
(1: 1) on performing the refolding procedure in the 
presence of trypsin-Sepharose. 
Neither of the two proteinase-reactive activities 
was detectable in the ultrafiltered flow-through 
fractions from affinity columns combined with all 
buffers used to remove nonspecifically bound 
proteins. 
This clearly demonstrates that the stoichiometric 
ratio of 1: 1 was not the result of a simple affinity 
chromatography step on trypsin-Sepharose. The 
relative increase in trypsin-inhibitory material after 
refolding and affinity chromatography on trypsin- 
Sepharose and the constant amounts of chymo- 
trypsin-reactive material - which is detectable only 
in the specifically eluted protein - rule out this 
possibility. 
Figs 4-6. (From left to right) Summary of titration experiments 
in both proteinase-reactive subdomains of the Pi-Pro (fig.4), 
the Pi-Pro (fig.5) and Pj -Leu (fig.6) variants. Amount of: (a) 
trypsin-reactive material after refolding in solution without 
trypsin-Sepharose as described [8]; (b) trypsin-reactive material 
after refolding in the presence of trypsin-Sepharose; (c) 
chymotrypsin-reactive material (the corresponding titration 
curves do not depend on the refolding method as shown in 
fig.2b,d). 
4. DISCUSSION 
One of the major problems faced during the 
course of protein engineering studies is to detect 
and to control refolding problems in a protein 
modified by site-directed mutagenesis. In this 
respect, the Bowman-Birk inhibitor of serine pro- 
teinases turned out to be an excellent model 
protein. 
The present article on the refolding protocol us- 
ing trypsin-Sepharose as a matrix with a com- 
plementary structure for the renaturation of 
mutant proteinase inhibitors, provides the first 
description of such a technique. This method 
should also be of interest for general use in protein 
engineering studies on other proteinase inhibitors 
from different families. The general approach, 
however, may be of even broader significance. The 
activation of inactive mutant enzymes by specific 
antibodies has been reported previously [IS] and 
might be used similarly. 
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